N-[4-[(5-ethyl-11-methyl-6-oxo-pyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-3-methoxy-phenyl]methanesulfonamide

ID: ALA4644273

PubChem CID: 134457677

Max Phase: Preclinical

Molecular Formula: C22H24N6O4S

Molecular Weight: 468.54

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN1C(=O)c2ccccc2N(C)c2nc(Nc3ccc(NS(C)(=O)=O)cc3OC)ncc21

Standard InChI:  InChI=1S/C22H24N6O4S/c1-5-28-18-13-23-22(24-16-11-10-14(12-19(16)32-3)26-33(4,30)31)25-20(18)27(2)17-9-7-6-8-15(17)21(28)29/h6-13,26H,5H2,1-4H3,(H,23,24,25)

Standard InChI Key:  JVVFSGBLMWRDED-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   24.4383  -17.4073    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0180  -17.9932    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   25.2325  -17.1923    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.8167  -18.2070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.4373  -18.5738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.6386  -18.3640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0595  -18.9464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2597  -18.7351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0444  -17.9356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6295  -17.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4157  -16.5522    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.0005  -15.9715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4245  -17.5649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2457  -17.7217    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0317  -16.9230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2270  -16.7933    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9377  -16.0206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4630  -15.3895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2637  -15.5264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5514  -16.2946    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2833  -14.5862    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.8639  -14.0013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6542  -13.2068    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5406  -14.2212    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5406  -13.3948    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.7974  -14.5662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1946  -13.9959    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4063  -14.2344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2140  -15.0366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8134  -15.6036    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6055  -15.3693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1117  -16.0206    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.7005  -16.7348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  2  3  2  0
  2  4  1  0
  5  2  1  0
  6  5  1  0
  7  6  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
 10 11  1  0
 11 12  1  0
 13 10  1  0
  6 13  2  0
 14  9  1  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 18 19  1  0
 20 19  2  0
 15 20  1  0
 21 18  1  0
 21 22  1  0
 22 23  1  0
 24 21  1  0
 24 25  2  0
 26 24  1  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 31 30  1  0
 26 31  2  0
 31 32  1  0
 32 17  1  0
 32 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4644273

    ---

Associated Targets(Human)

DCLK1 Tchem Serine/threonine-protein kinase DCLK1 (1025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LRRK2 Tchem Leucine-rich repeat serine/threonine-protein kinase 2 (6390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 468.54Molecular Weight (Monoisotopic): 468.1580AlogP: 3.35#Rotatable Bonds: 6
Polar Surface Area: 116.76Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.57CX Basic pKa: 3.31CX LogP: 1.98CX LogD: 1.98
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.57Np Likeness Score: -1.47

References

1. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS..  (2020)  Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one Scaffold.,  63  (14): [PMID:32530623] [10.1021/acs.jmedchem.0c00596]

Source